Single Chain Antibody definition

Single Chain Antibody means a single chain polypeptide having binding affinity for an antigen and a defined amino acid sequence whereby such polypeptide comprises (i) a first polypeptide segment having a light chain variable region, (ii) a second polypeptide having a heavy chain variable region, and (iii) at least one peptide linker linking the first and second polypeptides into a single chain polypeptide.
Single Chain Antibody or “SCA” means an Antibody having binding affinity for an Antigen whereby such Antibody comprises (a) a polypeptide segment having a light chain 6 \\PH - 037750/000002 - 398853 v1
Single Chain Antibody means a single chain polypeptide having a binding affinity for a cell surface antigen, and comprising: (a) a [***] having a [***], (b) a [***] having a [***], and (c) at least [***] the [***] and [***] into a single chain polypeptide. *** Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4), and 240.24b-2

Examples of Single Chain Antibody in a sentence

  • A year later forensic tests verified that it was a wolf (Brokaw 2002).

  • M., Cygler, M.: Structure of a Single -Chain Antibody Variable Domain (Fv) Fragment Complexed with a Carbohydrate Antigen at 1.7-A Resolution .

  • Localization of Isoketal Adducts In Vivo Using an Anti- Isoketal Single Chain Antibody.

  • However, RPRP and Introgen acknowledge that much of the preliminary research and preclinical studies on the Collaboration Products that are Single Chain Antibody Products may be performed by RPRP in France.

  • Daunert, "Fusion Proteins of a Single Chain Antibody and Photoproteins for Assay development in the Detection of Salmonella Antigen", 216th ACS National Meeting, March 21, 1999, Anaheim, CA.

  • RPRP and Introgen will mutually agree upon a Product Plan and Budget for the Single Chain Antibody Products, as contemplated in Section 3.4 of the Agreement.

  • Without limiting the foregoing, it is understood that Section 6.2 shall continue to apply to all Single Chain Antibody Products that are not being developed as Collaboration Products, and that funding for Introgen's conduct of the Early Stage Clinical Development of the Collaboration Products that are Single Chain Antibody Products will be as provided in Article 4 of the Agreement.

  • In addition, RPRP agrees to include in the reports provided to the Development Committee under Section 2.4.3 of the Agreement a summary of RPRP's activities with respect to the research and development of the Single Chain Antibody Products.

  • Directed in Vitro Evolution and Crystallographic Analysis of a Peptide-binding Single Chain Antibody Fragment (scFv) with Low Picomolar Affinity.

  • He may be declared bankrupt but the bankruptcy shall not include funds w hich are not invested in the business nor shall it have any effect w ith regard to the minor or the legally incompetent person.


More Definitions of Single Chain Antibody

Single Chain Antibody means one single-chain antibody binding to a certain antigen and the cDNA which produces the SINGLE-CHAIN ANTIBODY as specified in Schedule I attached hereto and made a part hereof.

Related to Single Chain Antibody

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compound means [***].

  • Opioid antidote means any drug, regardless of dosage amount or method of administration, which has been approved by the United States Food and Drug Administration (FDA) for the treatment of an opioid overdose. “Opioid antidote” includes, but is not limited to, naloxone hydrochloride, in any dosage amount, which is administered through nasal spray or any other FDA-approved means or methods.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Opioid antagonist means a drug that binds to opioid

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Collaborating physician means the physician who,

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • Biosimilar means a biological product that is highly similar to a specific reference biological

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Diagnostic mammography means a method of screening that

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • ingredient means any substance, including a food additive used in the manufacture or preparation of food and present in the final product, possibly in a modified form;